Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation
出版年份 2020 全文链接
标题
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation
作者
关键词
-
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-03-09
DOI
10.1161/circoutcomes.119.005969
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France
- (2018) Shuk-Li Collings et al. Archives of Cardiovascular Diseases
- Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
- (2018) Simone Bonde Haastrup et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands
- (2018) Maartje S. Jacobs et al. CURRENT MEDICAL RESEARCH AND OPINION
- Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants
- (2018) Chinmay G. Deshpande et al. CURRENT MEDICAL RESEARCH AND OPINION
- Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia
- (2018) Ainhoa Gomez-Lumbreras et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
- (2018) Gregory Y. H. Lip et al. PLoS One
- Dabigatran persistence and adherence in New Zealand: a nationwide retrospective observational study
- (2018) Paul Harper et al. BMJ Open
- Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation
- (2018) Srinivas Annavarapu et al. Journal of Comparative Effectiveness Research
- Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation
- (2017) Cynthia A Jackevicius et al. HEART
- Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
- (2017) Miney Paquette et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study
- (2017) Antonios Douros et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study
- (2017) Géric Maura et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies
- (2017) Tanja Mueller et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
- (2017) Beenish S. Manzoor et al. PHARMACOTHERAPY
- Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases
- (2017) Géric Maura et al. PHARMACOTHERAPY
- Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
- (2017) Morten Lamberts et al. Journal of the American Heart Association
- Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation
- (2017) Colleen A. McHorney et al. Journal of Managed Care & Specialty Pharmacy
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data
- (2017) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany
- (2017) Shuk-Li Collings et al. PLoS One
- Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
- (2016) Maja Hellfritzsch et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States
- (2016) Tim Bancroft et al. CLINICAL THERAPEUTICS
- Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation
- (2016) Colleen A. McHorney et al. CLINICAL THERAPEUTICS
- Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience
- (2016) Leon A. Simons et al. CURRENT MEDICAL RESEARCH AND OPINION
- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
- (2016) Jan Beyer-Westendorf et al. EUROPACE
- Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States
- (2016) Craig I. Coleman et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke
- (2016) Mark J. Alberts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
- (2016) Anuj Shah et al. STROKE
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
- (2016) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
- (2016) Semira Abdi Beshir et al. International Journal of Clinical Pharmacy
- Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
- (2016) Michelle E Johnson et al. BMJ Open
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
- (2016) Craig I. Coleman et al. PLoS One
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
- (2015) D.M. Adcock et al. THROMBOSIS RESEARCH
- Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
- (2015) Meijia Zhou et al. Journal of Managed Care & Specialty Pharmacy
- Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration
- (2014) Supriya Shore et al. AMERICAN HEART JOURNAL
- Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
- (2014) François Laliberté et al. CURRENT MEDICAL RESEARCH AND OPINION
- Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
- (2014) Winnie W. Nelson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
- (2014) Mei Han Ho et al. PLoS One
- Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
- (2013) Susan Colilla et al. AMERICAN JOURNAL OF CARDIOLOGY
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of dosing frequency on chronic cardiovascular disease medication adherence
- (2012) Craig I. Coleman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
- (2008) Donald E. Morisky et al. Journal of Clinical Hypertension
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search